0001351615-18-000001.txt : 20181108 0001351615-18-000001.hdr.sgml : 20181108 20181108161609 ACCESSION NUMBER: 0001351615-18-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20181108 DATE AS OF CHANGE: 20181108 EFFECTIVENESS DATE: 20181108 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SIAMAB THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001351615 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-325402 FILM NUMBER: 181169872 BUSINESS ADDRESS: STREET 1: 90 BRIDGE STREET, SUITE 100 CITY: NEWTON STATE: MA ZIP: 02458 BUSINESS PHONE: 800-513-1569 MAIL ADDRESS: STREET 1: 90 BRIDGE STREET, SUITE 100 CITY: NEWTON STATE: MA ZIP: 02458 FORMER COMPANY: FORMER CONFORMED NAME: Sialix, Inc. DATE OF NAME CHANGE: 20110817 FORMER COMPANY: FORMER CONFORMED NAME: Gc-Free, Inc. DATE OF NAME CHANGE: 20100319 FORMER COMPANY: FORMER CONFORMED NAME: GcFree Inc DATE OF NAME CHANGE: 20060131 D 1 primary_doc.xml X0708 D LIVE 0001351615 SIAMAB THERAPEUTICS, INC. 90 BRIDGE STREET, SUITE 100 NEWTON MA MASSACHUSETTS 02458 800-513-1569 DELAWARE Sialix, Inc. Gc-Free, Inc. GcFree Inc Corporation true Jeffrey Behrens c/o Siamab Therapeutics, Inc. 90 Bridge Street, Suite 100 Newton MA MASSACHUSETTS 02458 Executive Officer Director Brad Curley c/o Siamab Therapeutics, Inc. 90 Bridge Street, Suite 100 Newton MA MASSACHUSETTS 02458 Director Peter Kroon c/o Siamab Therapeutics, Inc. 90 Bridge Street, Suite 100 Newton MA MASSACHUSETTS 02458 Director Gary Pforzheimer c/o Siamab Therapeutics, Inc. 90 Bridge Street, Suite 100 Newton MA MASSACHUSETTS 02458 Director Biotechnology Decline to Disclose 06b false 2018-10-26 false true false 0 2000000 664501 1335499 false 21 0 0 0 false SIAMAB THERAPEUTICS, INC. /s/ Jeffrey Behrens Jeffrey Behrens President and Chief Executive Officer 2018-11-07